Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
3D Genomemedicine Inc is going to operate in USA
Plasma therapy accelerator (SARS-Hunter): a new solution for better antibody therapy for all coronavirus patients.
Visit us at MEDICA in Duesseldorf, Germany:
15.11. - 18.11.21
Visit us at BIO CEO & Investor Digital Conference New York, USA:
16.02. - 18.02.2021
Visit us at INVEST in Stuttgart, Germany:
23.03. - 24.04.21
Visit us at LSX World Congress 2021 Virtual London, UK:
01.02 - 05.02.2021
Visit us at Investival Showcase Virtual London, UK:
11.11. - 16.11.20
Usually we are composed of 3 or 4 members coming from different scientific fields to create innovative solutions in the field of medicine. Here are experiences of some of our team members:
Member 1: Experience in virology, immunology and stem cells along with the field of management and marketing. Long experience in creating immunotherapies.
Member 2: Experience in Stemcells including cancer stem cells, fluorescent techniques like flow cytometry and molecular biology